Aimovig

 

Generic name: erenumab
Brand name: Aimovig
Drug class: CGRP inhibitors

 

What is Aimovig?

Aimovig (erenumab) is a monoclonal antibody that inhibits the activation of a specific protein that triggers migraine attacks. The protein, known as calcitonin gene-related peptide (CGRP) is able to trigger blood vessels to dilate, which can create inflammation and migraine pain.

Aimovig is a prescription medication that is prescribed to treat the prevention of migraine in adults.

Aimovig can also be used for other purposes that are not mentioned in this guideline.¶

Warnings

Before injecting Aimovig make sure you read the label on your single-dose prefilled autoinjector, or single-dose prefilled syringe, to ensure that you have the right medicine and the proper dosage.

Follow the directions on the label of your medication and on the label of your package. Inform your healthcare professionals about your medical ailments, allergies, as well as any medications you take.

Before you start taking this medicine, make sure to consult your doctor

It is not recommended to take Aimovig if an allergic person to Erenumab.

Aimovig is not a product that has been approved to be used by anyone younger than 18 years of age.

Inform your doctor if you have ever suffered from:

• An allergic reaction to the latex.

Consult your doctor if are expecting or planning to be pregnant. It’s not clear if the medication erenumab could harm the unborn baby. But, experiencing migraine headaches in pregnancy could lead to complications like preeclampsia (dangerously high blood pressure that could result in medical problems for both the mother and the baby). The benefits of avoiding migraines could outweigh the risks for the baby.

It is not recommended to breastfeed during this medication. Talk to your doctor about any potential risks.

How should I take Aimovig?

Follow the exact instructions for Aimovig given by your doctor. Follow all instructions on your prescription label, and review all medication guides and instructions sheets.

Aimovig is injected beneath the skin (subcutaneously) once per month. A doctor may show you the proper use of the medication yourself.

If your healthcare professional prescribes the dose of 70 mg for you, then take one injection. If your healthcare professional recommends a dose of 140 mg make two injections, one after the other, and use a different autoinjector, or syringe prefilled in each of the injections. If you are planning to utilize the same site on your body for two injections, be sure that the second injection is not in the same place you had for the initial injection.

Follow and read carefully any instructions for use that come in your medication. Don’t use Aimovig if you aren’t familiar with all the instructions to use it correctly. Talk to your pharmacist or doctor for any concerns.

Preparing your Aimovig injection is only once you’re prepared to administer it. Avoid using when the medication is changing color or has particles. Contact your pharmacist to inquire about a new medication.

Every single-use syringe, autoinjector, or autoinjector is intended for one usage only. It is discarded after one time, even if there’s still some medicine within.

Be careful not to shake the syringe, or autoinjector otherwise you risk ruining the medicine.

The dosage you require can change if you change to a different brand or strength of this medication. Be sure to use only the strength and form the doctor recommends.

Keep Aimovig in its original packaging in the refrigerator in a cool, dark place far from light and heat. Do not put it in a freezer.

The medicine should be removed from the refrigerator and allow it to be at the temperature of room for 30 minutes prior to injecting your dose. Be sure to shield the medicine from sun. Avoid heating the medication by boiling hot water or using the microwave.

The medicine can be stored for up 7 days at temperatures at room temperature.

Use a needle or syringe just once, and then put them in a puncture-proof “sharps” container. Make sure you follow local or state laws on how to dispose of the container. Keep it out of range of pets and children.

Dosing information

Usual Adult Dose for Migraine Prophylaxis:

70 mg subcutaneously, once a month
Some patients might be benefited by 140 mg subcutaneously once per month.

Comments:
A amount of 140 milligrams is recommended to be administered in two consecutive injections subcutaneously that each contain 70 mg.

Use: As preventative management of migraine.

If I don’t take the dose?

If you fail when to have your dosage, or cannot get the dose according to the time, then take the missed dose as soon as you are able to remember. Then, you are able to keep taking Aimovig a single every month starting after the date of the last dose.

If I take too much?

Get medical attention immediately or contact toll-free the Poison Help line at 1-800-222-1222.

What to avoid?

Do not inject this medicine into skin that is swollen, red or bruised, tender or hard.

Aimovig side effects

See a doctor immediately If you exhibit symptoms that indicate an allergy reaction Aimovig: hives; difficulty breathing, chest pain, or swelling of your lips, face or tongue.

Common side effects of Aimovig be:

• constipation or
• swelling, pain, or
• redness at the site where the medicine was injected.

This is not a comprehensive list of all side effects. others could happen. Contact your doctor for advice regarding medical adverse effects. You can report any side effects to the FDA at 1-800-FDA-1088.

What other medications could impact Aimovig?

Other medications can be incompatible with erenumab, such as prescription and over-the counter medicines as well as vitamins and herbal products. Inform your doctor about all the medicines you are currently taking and any medication you begin or stop taking.

More details

Always consult your doctor to make sure the information presented on this page is applicable to your specific situation.